XOMA Royalty Corporation Share Price
NASDAQ: XOMAXOMA Royalty Corporation Stock Performance
Open N/A | Prev. Close N/A | Circuit Range N/A |
Day Range N/A | Year Range N/A | Volume N/A |
Average Traded N/A |
XOMA Royalty Corporation Share Price Chart
XOMA Royalty Corporation Stock Fundamentals & Key Indicators
Market Cap N/A | PE Ratio (TTM) N/A | Dividend Yield N/A |
EPS (TTM) $1.53 | Revenue (TTM) $10.35M | Return On Equity (TTM) 37.78% |
Profit Margin 306.40% | Debt to Equity 0.41 | Quarterly Earnings Growth YoY 168.15% |
XOMA Royalty Corporation Quarterly Profit & Loss
All figures in USD
XOMA Royalty Corporation Annual Profit & Loss
All figures in USD
About XOMA Royalty Corporation
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
XOMA Royalty Corporation Historical Returns
| Month | Open | Close | Change % |
|---|